Company News in the Life Science Industry

»

Reset 

Gladstone Investigator to Direct UCSF's Graduate Program in Biological and Medical Informatics

SAN FRANCISCO, Dec. 11, 2019 /PRNewswire/ -- In search of treatments for human diseases, medical researchers rely on the latest technologies to gather vast amounts of information. Genomics studies, for example, collect data about millions of DNA sequences, generating huge datasets. To decipher... Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019
Related companies:  Gladstone Institutes | J David Gladstone Institutes

Amgen Announces 10% Increase In 2020 First Quarter Dividend

THOUSAND OAKS, Calif., Dec. 11, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the first quarter of 2020. The dividend will be paid on March 6, 2020, to all stockholders of record as of the close of business on Feb.... Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019
Related companies:  Amgen, Inc.

Historic State Milestone: West Virginia Hunting And Fishing License Application Now Includes Option For Organ Donation

PITTSBURGH, Dec. 11, 2019 /PRNewswire/ -- The Center for Organ Recovery & Education (CORE) is proud... Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019

Global T-Cell Therapy Market: Trends, Opportunities and Forecasts (2019-2026) - Therapy for Solid Tumors Expected to Emerge as a Lucrative Source of Revenue Generation

DUBLIN, Dec. 11, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019

Starlight Children's Foundation and Nintendo of America Unveil the Starlight Nintendo Switch Gaming Station for Hospitalized Kids

TACOMA, Wash., Dec. 11, 2019 /PRNewswire/ -- Starlight Children's Foundation, the organization dedicated to delivering happiness to seriously ill children and their families, and Nintendo of America today announced the newest addition to the nonprofit's popular Starlight Gaming program: the Starlight... Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019

Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets

KELOWNA, BC, Dec. 11, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a cannabinoid-based product company with industry leading extraction, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab,... Read more ››

By: PR Newswire Association LLC. - 11 Dec 2019
Related companies:  Valens GroWorks Corp.

SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes

TORONTO, Dec. 11, 2019 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2019.

Read more ››
By: PR Newswire Association LLC. - 11 Dec 2019
Related companies:  SQI Diagnostics Inc.

Zealand Pharma announces amendments to its Articles of Association following the granting of warrants

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Zealand Pharma A/S

ChromaDex Launches Tru Niagen® Pro 500, the Largest Serving of Patented Nicotinamide Riboside Available Worldwide

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  ChromaDex Inc.

Candidates proposed for the Board of Directors

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Novozymes A/S

Athenex Announces Details of Investor Event and Webcast at SABCS on December 13, 2019

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Athenex Inc.

BioCryst Submits New Drug Application for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  BioCryst Pharmaceuticals, Inc.

Viela Bio Announces Initiation of Phase 2b Trial of VIB4920 in Sjögren’s Syndrome

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Viela Bio, Inc.

ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  ProQR Therapeutics NV

BioXcel Therapeutics to Expand Study of BXCL701 into Multiple Advanced Solid Tumor Types

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  BioXcel Therapeutics, Inc.

Hemostemix Announces Corporate Update

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Hemostemix Inc.

Bellicum Pharmaceuticals Licenses Its CaspaCIDe® Safety Switch to MD Anderson

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Bellicum Pharmaceuticals, Inc.

Novelion Therapeutics Provides Update on Effective Date of Liquidation

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  Novelion Therapeutics Inc.

InnerScope Hearing Technologies (OTCQB: INND) to Present at Singular Research 14th Annual “Best of the Uncovered” Conference on December 12, 2019

Read more ››
By: GlobenewsWire - 11 Dec 2019

APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies